Sudip Paul Selected Research

Piroxicam (Feldene)

8/2022	Retraction Note to: Alleviation of glutamate-mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.
11/2020	Corrigendum to "Does Piroxicam really protect ischemic neurons and influence neuronal firing in cerebral ischemia? An exploration towards therapeutics" [Med Hypotheses 81 (2013) 429-435].
9/2015	Piroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a "brake" on neuronal excitability in ischemic stroke.
12/2014	Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.
9/2013	Does Piroxicam really protect ischemic neurons and influence neuronal firing in cerebral ischemia? An exploration towards therapeutics.
1/2013	Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.
10/2012	Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.
9/2012	Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sudip Paul Research Topics

Disease

13	Brain Ischemia (Cerebral Ischemia) 08/2022 - 12/2011
7	Stroke (Strokes) 05/2022 - 07/2012
5	Ischemic Stroke 09/2015 - 12/2011
4	Wounds and Injuries (Trauma) 12/2017 - 01/2016
4	Cerebral Infarction 01/2015 - 01/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 10/2017
3	Metabolic Diseases (Metabolic Disease) 05/2021 - 01/2016
3	Myocardial Infarction 10/2017 - 01/2015
3	Brain Edema (Cerebral Edema) 01/2015 - 01/2013
2	Neoplasms (Cancer) 06/2022 - 07/2016
2	Atherosclerosis 05/2022 - 01/2019
2	Obesity 01/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 10/2012
2	Ischemia 04/2014 - 01/2013
2	Reperfusion Injury 09/2013 - 01/2013
1	Carotid Artery Diseases 05/2022
1	Edema (Dropsy) 03/2022
1	Heart Failure 03/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	Huntington Disease (Huntington's Disease) 01/2022
1	Birth Weight (Birth Weights) 01/2022
1	Multiple Sclerosis 01/2022
1	Inflammation (Inflammations) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Overweight 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Insulin Resistance 01/2019
1	Hyperglycemia 01/2017
1	Vascular Diseases (Vascular Disease) 07/2016
1	Body Weight (Weight, Body) 01/2015
1	Infarction (Infarctions) 12/2014
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2014
1	Alcoholism (Alcohol Abuse) 10/2012
1	Substance-Related Disorders (Drug Abuse) 10/2012
1	Neuroinflammatory Diseases 09/2012
1	Cognitive Dysfunction 09/2012
1	Acidosis 07/2012

Drug/Important Bio-Agent (IBA)

8	Piroxicam (Feldene)FDA LinkGeneric 08/2022 - 09/2012
5	LipidsIBA 01/2022 - 01/2015
5	AntioxidantsIBA 12/2017 - 12/2014
4	PlasmalogensIBA 01/2022 - 01/2019
4	EnzymesIBA 12/2017 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2015 - 12/2011
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 10/2017 - 01/2015
3	Neuroprotective AgentsIBA 01/2015 - 07/2012
3	Malondialdehyde (Propanedial)IBA 01/2015 - 01/2013
3	NitritesIBA 01/2015 - 01/2013
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2013 - 09/2012
2	gamma-Aminobutyric Acid (GABA)IBA 08/2022 - 12/2014
2	Glutamic Acid (Glutamate)FDA Link 08/2022 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2022
2	Protein Kinase CIBA 09/2021 - 04/2014
2	MelatoninIBA 09/2021 - 04/2014
2	Biological ProductsIBA 05/2021 - 09/2012
2	Glutathione PeroxidaseIBA 12/2017 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 07/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2014 - 09/2012
1	Indicators and Reagents (Reagents)IBA 05/2022
1	Adenosine Monophosphate (AMP)IBA 03/2022
1	mesoglycanIBA 03/2022
1	Ether (Diethyl Ether)IBA 01/2022
1	Free RadicalsIBA 01/2022
1	SynucleinsIBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021
1	Glycerophospholipids (Phosphoglycerides)IBA 05/2021
1	Methylcellulose (BFL)IBA 01/2021
1	Superoxide DismutaseIBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 12/2017
1	Glutathione (Reduced Glutathione)IBA 10/2017
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2017
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 10/2017
1	Insulin (Novolin)FDA Link 01/2017
1	oxidized low density lipoproteinIBA 01/2017
1	Adiponectin ReceptorsIBA 01/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 09/2015
1	ResveratrolIBA 01/2015
1	Troponin IIBA 01/2015
1	ifenprodilIBA 10/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2012
1	AcidsIBA 09/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012
1	QuercetinIBA 07/2012
1	Acid Sensing Ion ChannelsIBA 07/2012
1	FlavonoidsIBA 07/2012
1	CalciumIBA 12/2011
1	MagnesiumIBA 12/2011
1	Minocycline (Cyclops)FDA LinkGeneric 12/2011

Therapy/Procedure

5	Therapeutics 05/2021 - 12/2011
3	Oral Administration 12/2017 - 01/2016
2	Subcutaneous Injections 10/2017 - 01/2015
2	Drug Therapy (Chemotherapy) 10/2012 - 09/2012
1	Precision Medicine 06/2022
1	Surgical Amputation (Amputations) 07/2016